Press Release

Genedata, the leading provider of enterprise software for biopharmaceutical R&D, today announced a new release of its first-in-class Genedata Selector® software platform that enables the automation of complex next-generation sequencing (NGS) based workflows. The new release Genedata Selector 7.0 provides ...

Web-based solution offers advanced biological analysis and interpretation of Single Cell Clusters in tumor genome profiling experiments ROSALIND®, a software leader in extracting meaningful insights...

The new LT Kit reduces the startup cost for a single experiment, enabling a broader base of scientists to conduct single cell analysis. In addition, scientists...

InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, today announced that preclinical data investigating the Company’s...

HepaTx, Namocell, and Takara Bio USA, announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like...

MemVerge®, the pioneers of Big Memory software and Analytical BioSciences, a leader in single cell genomics, today announced the companies have accelerated the time-to-results for single-cell RNA sequencing (scRNA-seq) analysis by using Big...

Seven Bridges is supporting Pfizer in the development of a data management and collaboration solution for the biopharmaceutical company's single-cell ribonucleic acid (RNA) sequencing...

Resolve Biosciences, the pioneer in Molecular Cartography™, today announced initial results from several prominent early access collaborations with leading laboratories across Europe. Teams of scientists are...

Molecular Stethoscope Inc, a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/NASH patients with clinically...

OmniSeq®, an innovator in next generation sequencing in oncology, today announced its collaboration with the University of Pittsburgh Medical Center (UPMC) to employ its RNA sequencing (RNA-seq) gene expression profile assay for selecting immunotherapy combinations for patients in a Phase II clinical ...